PACIFIC VIEW ASSET MANAGEMENT, LLC - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 314 filers reported holding BLUEBIRD BIO INC in Q2 2018. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
PACIFIC VIEW ASSET MANAGEMENT, LLC ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q2 2018$737,000
+204.5%
4,689
+231.1%
0.58%
+220.3%
Q1 2018$242,000
-44.4%
1,416
-42.0%
0.18%
-37.0%
Q4 2017$435,0002,4410.29%
Other shareholders
BLUEBIRD BIO INC shareholders Q2 2018
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 6,335,528$40,104,0004.92%
qPULA Trading Management LP 14,344$91,0000.80%
Frazier Life Sciences Management, L.P. 1,440,757$9,120,0000.70%
Ikarian Capital, LLC 462,628$2,928,0000.58%
Birchview Capital, LP 98,000$620,0000.44%
HealthCor Management, L.P. 455,000$2,880,0000.36%
Financial Advocates Investment Management 45,071$3,538,0000.29%
PDT Partners, LLC 262,767$1,663,0000.25%
Monaco Asset Management SAM 80,000$506,0000.19%
Summit X, LLC 103,424$651,0000.19%
View complete list of BLUEBIRD BIO INC shareholders